Production Of GlaxoSmithKline Plc's Ziagen HIV Oral Liquid Medicine

Trefwoorden

Bottles of Ziagen, an HIV oral liquid medication, move down the... Nieuwsfoto'sAids,Canada,Dokter,Financiën,Fles,Gezondheidszorg en medicijnen,Hiv,Hoofdkantoor,Horizontaal,Medicijnen,Met de mond,Mississauga,Noord- & Zuid-Amerika,Ontario - Canada,Toronto,Verenigde Staten,Verpakking,VloeistofPhotographer Collection: Bloomberg 2010 BloombergBottles of Ziagen, an HIV oral liquid medication, move down the packaging line at the GlaxoSmithKline Canada Inc. headquarters in Mississauga, Ontario, Canada, on Monday, Dec. 13, 2010. Global sales of existing HIV medicines will peak at $12 billion in 2012, then halve by 2019 as patent expiries increase competition from generic drugs, according to a report by Datamonitor Group earlier this year. Photographer: Norm Betts/Bloomberg via Getty Images